In National Advertising Division Challenge, Begin Anew Medspa Voluntarily Discontinues Claims For Compounded Tirzepatide

(MENAFN- iCrowdNewsWire) New York, NY, June 9, 2025 – BBB National Programs' National Advertising Division reviewed a challenge brought by Eli Lilly and Company regarding express and implied advertising claims made by Begin Anew MedSpa concerning the efficacy and benefits of its compounded tirzepatide medication.

The challenged health-related claims, including claims that Begin Anew's Tirzepatide + B12 product is FDA approved, allows users to achieve (“fast and extreme”) weight loss without having to make lifestyle changes, and that its unique B12 formulation reduces nausea, appeared on Begin Anew's website.

During the inquiry, Begin Anew informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.

In its advertiser statement, Begin Anew MedSpa stated it is“dedicated to supporting the self-regulatory process and are fully devoted to promoting truthful advertising.“

All BBB National Programs case decision summaries can be found in the case decision library . For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive . Per NAD/NARB Procedures, this release may not be used for promotional purposes.

About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.

About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.

MENAFN09062025003318003403ID1109653078